A focus of the nanoprecipitation by solvent displacement: example of poly(MAOTIB) intended to in vivo applications
-
Published:2019-03-13
Issue:1
Volume:1
Page:20-26
-
ISSN:2650-7501
-
Container-title:European Journal of Pharmaceutical Research
-
language:
-
Short-container-title:Eur. J. Pharm. Res.
Author:
Wallyn Justine1, Vandamme Thierry1, Anton Nicolas1
Affiliation:
1. University of Strasbourg, CNRS, CAMB UMR 7199, F-67000 Strasbourg, France
Abstract
Through this study, we propose to specifically focus on a particular stage of the fabrication of polymeric nanoparticles intended to be used as contrast agent for biomedical X-ray imaging. These nanoparticles, made from nanoprecipitation of preformed polymer, poly(MAOTIB) (poly(2-methacryloyloxyethyl(2,3,5-triiodobenzoate))) follow a solvent displacement process. This method, widely used in literature, is sensitive to the formulation and process parameters such as nature and concentrations of surfactant and polymer, solvent / non-solvent ratio, rate of addition of one phase in the other one, respective volumes of the phase, and homogenization shearing rate. On the other hand, in function of the aimed administration route, the final suspension should obey to specific constraints on final product, e.g. size range and polydispersity, final particle concentration (i.e. iodine concentration) and surfactant concentration. In the present work, we report a specific investigation on the nanoprecipiation of poly(MAOTIB) in tetrahydrofuran, dropped in water or ethanol (as non-solvent) and stabilized by nonionic surfactant. The objective is to show and explain the potentials and limitations of such the process, but also to provide a guidance on the way to optimize it.
Publisher
European Academy of Applied and Social Sciences (EURAASS)
Reference36 articles.
1. Anton, N., Parlog, A., Bou About, G., Attia, M. F., Wattenhofer-Donzé, M., Jacobs, H., … Vandamme, T. F. (2017). Non-invasive quantitative imaging of hepatocellular carcinoma growth in mice by micro-CT using liver-targeted iodinated nano-emulsions. Scientific Reports, 7(1). 2. Anton, N., & Vandamme, T. (2009). The universality of low-energy nano-emulsification. International Journal of Pharmaceutics, 377(1), 142–147. 3. Attia, M. F., Anton, N., Akasov, R., Chiper, M., Markvicheva, E., & Vandamme, T. F. (2016). Biodistribution and toxicity of X-ray iodinated contrast agent in nano-emulsions in function of their size. Pharm. Res., 33(3), 603–614. 4. Attia, M. F., Anton, N., Chiper, M., Akasov, R., Anton, H., Messaddeq, N., … Vandamme, T. F. (2014). Biodistribution of X-ray iodinated contrast agent in nano-emulsions is controlled by the chemical nature of the oily core. ACS Nano, 8(10), 10537–10550. 5. Aviv, H., Bartling, S., Kieslling, F., & Margel, S. (2009). Radiopaque iodinated copolymeric nanoparticles for X-ray imaging applications. Biomaterials, 30(29), 5610–5616.
|
|